OPKO Health, Inc. (OPK)
1.66
+0.05
(+3.11%)
USD |
NASDAQ |
Oct 20, 16:00
1.66
0.00 (0.00%)
Pre-Market: 08:26
OPKO Health Research and Development Expense (TTM) : 125.22M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.22M |
| March 31, 2026 | 122.39M |
| December 31, 2025 | 124.03M |
| September 30, 2025 | 121.66M |
| June 30, 2025 | 120.35M |
| March 31, 2025 | 114.09M |
| December 31, 2024 | 105.19M |
| September 30, 2024 | 94.19M |
| June 30, 2024 | 84.85M |
| March 31, 2024 | 78.93M |
| December 31, 2023 | 89.60M |
| September 30, 2023 | 89.70M |
| June 30, 2023 | 89.06M |
| March 31, 2023 | 88.15M |
| December 31, 2022 | 73.86M |
| September 30, 2022 | 75.36M |
| June 30, 2022 | 74.87M |
| March 31, 2022 | 75.84M |
| December 31, 2021 | 76.84M |
| September 30, 2021 | 73.30M |
| June 30, 2021 | 73.48M |
| March 31, 2021 | 72.87M |
| December 31, 2020 | 75.32M |
| September 30, 2020 | 80.86M |
| June 30, 2020 | 92.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 103.06M |
| December 31, 2019 | 117.83M |
| September 30, 2019 | 128.16M |
| June 30, 2019 | 128.30M |
| March 31, 2019 | 129.23M |
| December 31, 2018 | 125.59M |
| September 30, 2018 | 126.50M |
| June 30, 2018 | 128.85M |
| March 31, 2018 | 132.76M |
| December 31, 2017 | 126.44M |
| September 30, 2017 | 119.79M |
| June 30, 2017 | 111.71M |
| March 31, 2017 | 110.60M |
| December 31, 2016 | 112.66M |
| September 30, 2016 | 111.23M |
| June 30, 2016 | 106.35M |
| March 31, 2016 | 104.39M |
| December 31, 2015 | 101.74M |
| September 30, 2015 | 102.34M |
| June 30, 2015 | 103.92M |
| March 31, 2015 | 90.60M |
| December 31, 2014 | 86.13M |
| September 30, 2014 | 82.72M |
| June 30, 2014 | 72.67M |
| March 31, 2014 | 65.49M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median